P104
HCC risk stratification during long-term Bulevirtide therapy: performance of PAGE-B and AMAP in compensated HDV cirrhosis
MP. Anolli, E. Degasperi, D. Sambarino, M. Borghi, R. Perbellini, L. Gheorghe, M. Chitul, C. Schramm, H. Schmidt, M. Jachs, T. Reiberger, I. Carey, K. Agarwal, M. Buti, A. Palom, G. D’Offizi, F. di Maria, C. Zöllner, F. Tacke, C. Dietz-Fricke, H. Wedemeye